National Brain Tumor Society-Parker Institute for Cancer Immunotherapy Workshop:
The Future of Cancer Immunotherapy for Brain Tumors
National Brain Tumor Society teamed up with the Parker Institute for Cancer Immunotherapy (PICI) to host a collaborative workshop on the future of immuno-oncology for brain tumors. The workshop’s goal was to explore the state of the field, share recent data and ideas, and ultimately identify challenges and opportunities to make immunotherapy a reality for pediatric and adult patients with a brain tumor.
A report from that meeting – authored by NBTS’s Chief Scientific Officer, Kirk Tanner, Director of Research, Olga Futer, and leaders from PICI, as well as expert researchers – was recently published as a white paper in the Journal of Translational Medicine. The white paper offers key takeaways from the meeting and identifies promising new technologies and several proposed areas of focus and emphasis to improve the impact of immunotherapy in brain tumors.